Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | TUBB4A | P04350 | 3/20 | 0.32 |
| ▸ | TUBB | P07437 | 3/20 | 0.32 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.32 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.32 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.32 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.32 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.32 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.32 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.32 |
| ▸ | TUBA3E | Q6PEY2 | 3/20 | 0.32 |
| ▸ | TUBA1A | Q71U36 | 3/20 | 0.32 |
| ▸ | TUBA1C | Q9BQE3 | 3/20 | 0.32 |
| ▸ | TUBB6 | Q9BUF5 | 3/20 | 0.32 |
| ▸ | TUBB2B | Q9BVA1 | 3/20 | 0.32 |
| ▸ | TUBB1 | Q9H4B7 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3703037 | 0.81 | HTT (0.37) | EGFRPDGFRBKDRGBA1ALOX15 | |
| SCHEMBL7607941 | 0.76 | KDM4E (0.35) | MAPTALDH1A1 | |
| SCHEMBL190033 | 0.75 | TDP1 (0.31) | TDP1ALDH1A1 | |
| SCHEMBL29569254 | 0.72 | HTT (0.41) | ALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL1709918 | 0.72 | HTT (0.41) | ALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL7601802 | 0.71 | ALDH1A1 (0.37) | EGFRPDGFRBKDRTUBB4ATUBB | |
| SCHEMBL3713429 | 0.71 | XDH (0.37) | MEN1KMT2ACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL3715489 | 0.68 | SYK (0.41) | MEN1KMT2AALOX15TDP1ALDH1A1 | |
| SCHEMBL3708672 | 0.68 | PDE4A (0.44) | HTT | |
| SCHEMBL17464086 | 0.67 | KDM4E (0.52) | MEN1KMT2AMAPTTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8551981-B2 | Furo[3,2-d]pyrimidine compounds | ABBVIE INC. (US) | 2013-10-08 | — | — | US | disclosed |
| US-20120122846-A1 | FURO[3,2-d]PYRIMIDINE COMPOUNDS | ABBOTT LABORATORIES (US) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122846-A1 | FURO[3,2-d]PYRIMIDINE COMPOUNDS | CDK2, DPYD, CDK3 | EGFR 1238/4885PDGFRB 564/4885KDR 1487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.